• Info
  • Insider Ownership

Insider Trading & Ownership of Samuel Kintz

Location
Boulder, CO
Summary
The estimated net worth of Samuel Kintz is at least $19,427,552 dollars as of 19 Nov 2025. Samuel Kintz is the PRESIDENT AND CEO, Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $19.43M.
Signature
/s/ Ben Hohl, by power of attorney
All Insider Reports
All Insider Reports

Notify me when Samuel Kintz files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Samuel Kintz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director $19,427,552 -$2,100,217 -9.8% 17 Nov 2025

Insider Transactions Reported by Samuel Kintz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.